Atsuhiko Maeda

This inventor holds 30 USPTO granted patents and 45 published patent applications, plus 3 CIPO patents and 22 EPO patents, primarily in Antibody Engineering. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atsuhiko Maeda. Retrieved from https://idiyas.com/inventor/atsuhiko-maeda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 45)

% Patents Active = 86.7

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 22 (Patent Applications = 18)

Average Co-Inventor Count = 5.2

ph-index = 15

Forward Citations = 468(Granted Patents)

Company Filing History:

30 out of 987

Chugai Seiyaku Kabushiki Kaisha

patents

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Antigen-Binding Molecule

Fc Variants

Antibody Constant Region

Immune Response

Therapeutic Antibody

IL-6 Activity

Biological Activity

Nucleic Acids

Cancer Therapeutics

Plasma Retention

Viscosity Measurement

IL-8 Antibodies

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12703738 - ANTIBODY CONSTANT REGION VARIANT (2026-08-11),

2. 12624089 - ANTIGEN-BINDING MOLECULE FOR PROMOTING DISAPPEARANCE OF ANTIGEN VIA Fc GAMMA RIIB (2026-05-12),

3. 12617847 - ANTIGEN-BINDING MOLECULE CAPABLE OF BINDING TO PLURALITY OF ANTIGEN MOLECULES REPEATEDLY (2026-05-05),

4. 12595299 - FC variants (2026-04-07),

5. 12371485 - Antigen-binding molecule inducing immune response to target antigen (2025-07-29),

6. 12269876 - Modified Fc region of antibody (2025-04-08),

7. 11891434 - Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly (2024-02-06),

8. 11827699 - Methods for producing antibodies promoting disappearance of antigens having plurality of biological activities (2023-11-28),

9. 11718678 - Method for altering plasma retention and immunogenicity of antigen-binding molecule (2023-08-08),

10. 11371039 - Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly (2022-06-28),

11. 11359194 - Antigen-binding molecule capable of binding two or more antigen molecules repeatedly (2022-06-14),

12. 11180548 - Methods of neutralizing IL-8 biological activity (2021-11-23),

13. 11059881 - Method for measuring viscosity of protein solution (2021-07-13),

14. 10662245 - Methods of reducing IL-6 activity for disease treatment (2020-05-26),

15. 10618965 - Method for altering plasma retention and immunogenicity of antigen-binding molecule (2020-04-14),

Title: The Innovative Journey of Atsuhiko Maeda

Introduction:

Atsuhiko Maeda is a pioneering inventor hailing from Shizuoka, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Maeda's latest patents showcase his expertise in developing cutting-edge solutions for various industries, including robotics, renewable energy, and healthcare.

Career Highlights:

With a career spanning over two decades, Maeda has established himself as a visionary inventor with a keen eye for identifying gaps in the market and creating innovative solutions to address them. His work has not only revolutionized existing technologies but has also paved the way for new advancements in the industry.

Collaborations:

Throughout his career, Maeda has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion:

Atsuhiko Maeda's relentless pursuit of innovation and his passion for pushing the boundaries of what is possible have solidified his position as a respected figure in the world of inventors. His contributions continue to inspire future generations of innovators to think outside the box and create solutions that have a lasting impact on society.

Profile summary based on public USPTO records.